je.st
news
Biogen and Sobi Announce European Medicines Agency Validates...
2015-06-26 10:44:02| Appliances - Topix.net
CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has accepted the Marketing Authorization Application of ALPROLIX A , a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA's review process.
Tags: agency
european
announce
medicines
Category:Consumer Goods and Services